A Genome-Wide CRISPR Interference Screen Reveals an StkP-Mediated Connection between Cell Wall Integrity and Competence in Streptococcus salivarius.


Journal

mSystems
ISSN: 2379-5077
Titre abrégé: mSystems
Pays: United States
ID NLM: 101680636

Informations de publication

Date de publication:
20 12 2022
Historique:
pubmed: 8 11 2022
medline: 23 12 2022
entrez: 7 11 2022
Statut: ppublish

Résumé

Competence is one of the most efficient bacterial evolutionary and adaptative strategies by synchronizing production of antibacterial compounds and integration of DNA released by dead cells. In most streptococci, this tactic is orchestrated by the ComRS system, a pheromone communication device providing a short time window of activation in which only part of the population is responsive. Understanding how this developmental process integrates multiple inputs to fine-tune the adequate response is a long-standing question. However, essential genes involved in the regulation of ComRS have been challenging to study. In this work, we built a conditional mutant library using CRISPR interference and performed three complementary screens to investigate competence genetic regulation in the human commensal Streptococcus salivarius. We show that initiation of competence increases upon cell wall impairment, suggesting a connection between cell envelope stress and competence activation. Notably, we report a key role for StkP, a serine-threonine kinase known to regulate cell wall homeostasis. We show that StkP controls competence by a mechanism that reacts to peptidoglycan fragments. Together, our data suggest a key cell wall sensing mechanism coupling competence to cell envelope integrity.

Identifiants

pubmed: 36342134
doi: 10.1128/msystems.00735-22
pmc: PMC9765292
doi:

Substances chimiques

Bacterial Proteins 0
Pheromones 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0073522

Références

Nature. 2012 Jun 13;486(7402):207-14
pubmed: 22699609
Nat Commun. 2017 Oct 11;8(1):854
pubmed: 29021534
PLoS Pathog. 2016 Dec 1;12(12):e1005980
pubmed: 27907189
Mol Cell. 2018 Apr 5;70(1):95-105.e4
pubmed: 29625042
Trends Cell Biol. 2016 Apr;26(4):262-271
pubmed: 26671200
Lett Appl Microbiol. 2007 Oct;45(4):398-404
pubmed: 17897382
Front Microbiol. 2019 Jun 19;10:1329
pubmed: 31275266
J Bacteriol. 2013 Apr;195(8):1845-55
pubmed: 23396911
BMC Microbiol. 2009 Jun 05;9:121
pubmed: 19500353
PLoS Genet. 2018 Jul 12;14(7):e1007531
pubmed: 30001325
PLoS Genet. 2022 May 25;18(5):e1010198
pubmed: 35613247
Nature. 2015 Oct 29;526(7575):719-22
pubmed: 26479034
Phys Biol. 2017 Jan 27;14(1):015001
pubmed: 28129205
ACS Synth Biol. 2015 Mar 20;4(3):228-39
pubmed: 24845455
J Bacteriol. 2017 Dec 20;200(2):
pubmed: 29109185
Nucleic Acids Res. 2020 Jan 8;48(D1):D265-D268
pubmed: 31777944
J Bacteriol. 2010 Mar;192(5):1444-54
pubmed: 20023010
J Bacteriol. 2013 Nov;195(22):5196-206
pubmed: 24039267
J Bacteriol. 2009 May;191(9):2973-84
pubmed: 19251860
J Mol Biol. 2021 Dec 3;433(24):167319
pubmed: 34688688
Cell. 2008 Oct 31;135(3):486-96
pubmed: 18984160
Genes (Basel). 2017 Jan 05;8(1):
pubmed: 28067778
J Bacteriol. 2014 Aug;196(15):2807-16
pubmed: 24837292
Mol Oral Microbiol. 2010 Jun;25(3):165-77
pubmed: 20536745
J Bacteriol. 2012 Apr;194(7):1777-88
pubmed: 22287513
Mol Microbiol. 2012 Feb;83(4):746-58
pubmed: 22211696
Cell. 2014 Apr 10;157(2):395-406
pubmed: 24725406
Appl Environ Microbiol. 2010 Dec;76(23):7870-7
pubmed: 20935129
Cell Host Microbe. 2021 Jan 13;29(1):107-120.e6
pubmed: 33120116
PLoS One. 2013 Dec 30;8(12):e83418
pubmed: 24386196
PLoS Pathog. 2018 Jun 8;14(6):e1007118
pubmed: 29883472
J Bacteriol. 2011 Dec;193(23):6552-9
pubmed: 21984782
Infect Immun. 2004 Aug;72(8):4895-9
pubmed: 15271957
Infect Immun. 2010 May;78(5):2209-20
pubmed: 20231406
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):E905-13
pubmed: 22431591
mSphere. 2018 Feb 7;3(1):
pubmed: 29435491
Nat Rev Microbiol. 2007 Mar;5(3):219-29
pubmed: 17277796
Infect Immun. 2004 Apr;72(4):2434-7
pubmed: 15039376
Mol Microbiol. 2013 Mar;87(6):1113-32
pubmed: 23323845
Mol Microbiol. 2015 Sep;97(6):1097-113
pubmed: 26062094
Mol Syst Biol. 2017 May 10;13(5):931
pubmed: 28490437
Genome Biol. 2015 Dec 16;16:281
pubmed: 26673418
Microbiol Mol Biol Rev. 2011 Mar;75(1):192-212
pubmed: 21372323
Microbiol Mol Biol Rev. 2003 Dec;67(4):686-723
pubmed: 14665680
Cell Rep. 2018 Nov 27;25(9):2390-2400.e3
pubmed: 30485808
J Appl Microbiol. 2001 Dec;91(6):1023-9
pubmed: 11851809
Cell Rep. 2018 Feb 13;22(7):1627-1638
pubmed: 29444418
Annu Rev Genet. 2017 Nov 27;51:311-333
pubmed: 28876981
Mol Microbiol. 2020 Jul;114(1):109-126
pubmed: 32189382
Mol Microbiol. 2019 Nov;112(5):1388-1402
pubmed: 31403729
J Bacteriol. 2001 Aug;183(15):4599-608
pubmed: 11443095
J Bacteriol. 2010 Apr;192(7):1761-73
pubmed: 20118250
Genome Announc. 2016 Feb 04;4(1):
pubmed: 26847886
J Mol Biol. 2019 Nov 22;431(23):4530-4546
pubmed: 31051177
Cells. 2021 Jul 30;10(8):
pubmed: 34440707
Mol Microbiol. 2009 Mar;71(6):1477-95
pubmed: 19170889
Virulence. 2011 Sep-Oct;2(5):435-44
pubmed: 21778817
J Bacteriol. 2007 Jun;189(11):4168-79
pubmed: 17416671
J Bacteriol. 2001 Dec;183(24):7295-307
pubmed: 11717289
Nucleic Acids Res. 2000 Jan 1;28(1):33-6
pubmed: 10592175
J Bacteriol. 2013 Jun;195(12):2912-20
pubmed: 23603743
Infect Genet Evol. 2015 Jul;33:343-60
pubmed: 25236918
PLoS One. 2011;6(5):e20127
pubmed: 21655290
Mol Microbiol. 2000 May;36(3):688-96
pubmed: 10844657
Mol Oral Microbiol. 2016 Dec;31(6):501-514
pubmed: 26513533
Front Microbiol. 2018 Nov 06;9:2678
pubmed: 30459743
mBio. 2022 Jan 4;:e0312521
pubmed: 35089064
Appl Environ Microbiol. 2001 Jun;67(6):2734-8
pubmed: 11375188
Nat Commun. 2018 May 15;9(1):1912
pubmed: 29765036
Front Microbiol. 2016 Jul 28;7:1162
pubmed: 27516759
mBio. 2011 Sep 20;2(5):
pubmed: 21933920
PLoS Pathog. 2014 May 01;10(5):e1004088
pubmed: 24788524
Mol Microbiol. 2010 Dec;78(6):1431-47
pubmed: 21143316
Front Microbiol. 2021 Mar 31;12:635227
pubmed: 33868193
Biosci Biotechnol Biochem. 2002 Apr;66(4):892-6
pubmed: 12036071

Auteurs

Adrien Knoops (A)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Alexandra Waegemans (A)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Morgane Lamontagne (M)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Baptiste Decat (B)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Johann Mignolet (J)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.
Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausannegrid.9851.5, Lausanne, Switzerland.

Jan-Willem Veening (JW)

Department of Fundamental Microbiology, Faculty of Biology and Medicine, University of Lausannegrid.9851.5, Lausanne, Switzerland.

Pascal Hols (P)

Louvain Institute of Biomolecular Science and Technology, Biochemistry and Genetics of Microorganisms, Université catholique de Louvain, Louvain-La-Neuve, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH